For CMV pregnancy prevention, focus on reducing contact with young children’s saliva and urine: wash your hands after diaper changes or wiping a nose, and avoid sharing food, drinks, or utensils. These habits may reduce exposure, but they cannot prevent every infection. A single possible contact does not mean you have CMV; if you feel unwell or are worried, contact your prenatal care provider to discuss whether testing is appropriate.
CMV Pregnancy Prevention Starts With Everyday Contact
Cytomegalovirus (CMV) is common, and many people have no symptoms when infected. Young children can shed the virus in saliva and urine, so routine caregiving tasks—such as changing diapers, helping with toileting, or cleaning a runny nose—can expose you to these fluids. Transmission generally involves contact with infected body fluids, not simply being in the same room.
Try these practical steps, especially if you regularly care for a child under five:
- Wash your hands thoroughly with soap and water after changing diapers, helping a child use the toilet, wiping their nose, or handling saliva-covered toys.
- Do not share cups, cutlery, food, or toothbrushes with young children.
- Avoid kissing a child on the mouth; choose a kiss on the forehead or a cuddle instead.
- Clean up urine or saliva carefully, then wash your hands.
You do not need to avoid children or stop caring for your family. The aim is to reduce direct contact with saliva and urine while keeping normal routines manageable.
What Hygiene Can—and Cannot—Do
There is evidence that counseling can help lower infection risk among pregnant people with frequent contact with young children. In a 2015 controlled study in Pavia and Turin, Italy, Maria Grazia Revello and colleagues in the CCPE Study Group followed CMV-seronegative pregnant women who had regular child contact. Four of 331 women given hygiene information and follow-up testing acquired CMV, compared with 24 of 315 women in an observational comparison group who were not informed or tested during pregnancy.
The results support hygiene counseling, but they do not mean the measures guarantee protection. The groups were not assigned in the same way as in a randomized trial, and the participants were selected for higher exposure risk in Italy. Your own risk may differ, and exposure can still happen despite careful habits.
Past CMV infection also does not make infection impossible: the virus can reactivate, or a person can acquire a different strain. Hygiene remains sensible regardless of whether you know your CMV status.
After Possible Exposure or CMV-Like Symptoms
Wash your hands after contact and return to your usual precautions. Contact alone does not confirm infection, and testing immediately after one encounter may not answer whether infection occurred. If you develop a fever, swollen lymph nodes, or a flu-like illness, tell your prenatal provider—especially if you have been around a young child who may be shedding CMV. Many infections cause no clear symptoms, so feeling well cannot rule them out either.
Your clinician can consider your symptoms, pregnancy stage, and any previous test results when deciding whether blood tests are useful. CMV tests can be difficult to interpret: clinicians may use IgG and IgM antibody tests and, in some situations, IgG avidity to assess whether infection may be recent. If testing suggests a new infection, ask for prompt specialist advice. Treatment decisions, including whether an antiviral is considered, require clinical assessment; do not try to manage CMV with medication on your own.
Why Testing Guidance Differs by Country
There is no single global approach to CMV screening in pregnancy. In the United States, routine screening has generally not been part of standard prenatal care; testing may be considered for symptoms or other clinical concerns. Australia recommends offering testing to women at increased risk and considering it when symptoms suggest CMV, rather than screening everyone routinely.
The European Congenital Infection Initiative’s 2024 consensus recommends early pregnancy serology and repeat testing every four weeks until 14–16 weeks for women who are seronegative. That is a European expert recommendation, not proof that every country has adopted the same national screening policy. Local practice can differ, including within Europe.
These differences reflect uncertainty about the benefits and drawbacks of screening everyone, as well as changing guidance on specialist management after a confirmed infection. Ask your midwife or doctor what your local pathway covers, particularly if you care for young children or develop a possible CMV-like illness. Seek clinical advice rather than relying on a home interpretation of test results.